article thumbnail

Indian Companies Blossom in the US Market

Business Consulting Agency

For Indian companies, venturing into the American market is a significant opportunity. In this comprehensive article, we will explore why Indian companies often experience remarkable success when entering the US market with the guidance of business consultants. The Role of Business Consultants in US Market Entry 1.

Company 52
article thumbnail

Combatting COVID-19 in Emerging Markets

Tom Spencer

These non-pharmaceutical interventions ( NPI’s ) presented challenges for many workers especially in manufacturing and production industries. Much less emphasis has been placed on developing tools suitable for emerging markets and the businesses in these economies. Obstacles in Emerging Markets. Contact Tracing Apps.

Marketing 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Creating a Product Line for Doctors

Business Consulting Agency

These products could range from innovative medical devices and equipment to proprietary pharmaceuticals or even educational materials. Once a successful product is developed, it can be mass-produced or licensed, opening doors for expansion into broader markets.

article thumbnail

Brent Saunders on Building a Bold New Allergan

BCG

Outside of emerging markets, those are strong turns of phrase for a man in his position. The pharmaceutical industry is coping with regulatory pressure to reign in drug prices and dealing with the expiration of profitable patents. But despite slower growth in mature markets, pharma is still a high-margin business that can save lives.

article thumbnail

Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis

Harvard Business

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

article thumbnail

Research: Innovation Suffers When Drug Companies Merge

Harvard Business

On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. What’s the reason for this?

article thumbnail

Lobbyists Are Behind the Rise in Corporate Profits

Harvard Business

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up. Corporate valuations are up as well.